Simulations Plus (SLP) Finds China Distributor For R&D Modeling Software
3/19/2014 9:39:40 AM
by Richard Daverman, PhD
March 18, 2014 -- Simulations Plus of California has signed up the Research Institute for Liver Diseases, located in Shanghai, to distribute its pharmaceutical discovery/development simulation and modeling software in China. Simulations calls its products “in silico consulting services” and positions them as a natural fit for RILD’s in vitro experimental systems. More details....
Stock Symbol: (NSDQ: SLP)
Help employers find you! Check out all the jobs and post your resume.
comments powered by